| Balance Sheets | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 7,511 | 6,951 | 6,532 | 7,558 |
| Short-term investments | 222 | 331 | 312 | 230 |
| Trade receivables, less allowances of 490 in 2025 and 439 in 2024 | 8,138 | 7,972 | 7,327 | 7,051 |
| Finished products | 4,130 | 4,319 | 4,063 | 4,173 |
| Work in process | 961 | 962 | 890 | 877 |
| Materials | 1,617 | 1,673 | 1,686 | 1,763 |
| Total inventories | 6,708 | 6,954 | 6,639 | 6,813 |
| Prepaid expenses and other receivables | 2,260 | 2,260 | 2,343 | 2,150 |
| Total current assets | 24,839 | 24,468 | 23,153 | 23,802 |
| Investments | 951 | 958 | 907 | 912 |
| Property and equipment, at cost | 24,816 | 24,472 | 23,418 | 22,857 |
| Less accumulated depreciation and amortization | 13,312 | 13,077 | 12,486 | 12,236 |
| Net property and equipment | 11,504 | 11,395 | 10,932 | 10,621 |
| Intangible assets, net of amortization | 5,598 | 5,920 | 6,261 | 7,352 |
| Goodwill | 23,971 | 23,952 | 23,359 | 23,658 |
| Deferred income taxes and other assets | 17,318 | 17,306 | 16,836 | 8,011 |
| Total assets | 84,181 | 83,999 | 81,448 | 74,356 |
| Trade accounts payable | 4,123 | 4,306 | 4,214 | 4,034 |
| Salaries, wages and commissions | 1,735 | 1,550 | 1,167 | 1,618 |
| Other accrued liabilities | 5,880 | 5,656 | 5,600 | 5,427 |
| Dividends payable | 1,030 | 1,030 | 1,032 | 956 |
| Income taxes payable | 469 | 390 | 485 | 713 |
| Current portion of long-term debt | 1,345 | 507 | 506 | 2,154 |
| Total current liabilities | 14,582 | 13,439 | 13,004 | 14,902 |
| Long-term debt | 11,596 | 12,930 | 12,736 | 12,825 |
| Post-employment obligations, deferred income taxes and other long-term liabilities | 6,739 | 6,801 | 6,644 | 6,601 |
| Preferred shares, one dollar par value authorized 1,000,000 shares, none issued | 0 | 0 | 0 | 0 |
| Common shares, without par value authorized 2,400,000,000 shares issued at stated capital amount shares 2025 1,996,743,794 2024 1,991,472,630 | 25,412 | 25,284 | 25,125 | 25,020 |
| Common shares held in treasury, at cost shares 2025 257,871,122 2024 259,774,639 | 16,877 | 16,610 | 16,612 | 16,476 |
| Earnings employed in the business | 49,103 | 48,467 | 47,715 | 39,056 |
| Accumulated other comprehensive income (loss) | -6,684 | -6,576 | -7,417 | -7,804 |
| Total abbott shareholders investment | 50,954 | 50,565 | 48,811 | 39,796 |
| Noncontrolling interests | 310 | 264 | 253 | 232 |
| Total shareholders investment | 51,264 | 50,829 | 49,064 | 40,028 |
| Total liabilities and shareholders' investment | 84,181 | 83,999 | 81,448 | 74,356 |
ABBOTT LABORATORIES (ABT)
ABBOTT LABORATORIES (ABT)